Sun Pharmaceutical Industries Limited (Sun Pharma), announced that one of its subsidiaries, S.C. Terapia S.A., Romania has acquired the Uractiv portfolio from Fiterman Pharma in Romania.
The Uractiv portfolio comprises food supplements including minerals, vitamins and adjuvants; cosmetics and medical devices used for maintaining urinary tract health. Uractiv is the No. 1 brand in its category in Romania, trusted by consumers for more than 10 years. The portfolio including 12 SKUs has annualised revenues of approximately US$ 8.7 million. The products cater to both adults and children, the statement said.
“We are excited to add Uractiv to our consumer healthcare portfolio in Romania. This acquisition is in line with our strategy to further expand our non-prescription product basket in Romania and neighbouring markets,” said Aalok Shanghvi, EVP & HeadGeneric R&D, Generic Global BD and Emerging Markets, Sun Pharma.
“We have a strong presence in Romania with Terapia being the number one company in the generics and OTC market. We will leverage our robust marketing and distribution strengths to grow these brands further,” he added.
HrNxt.com Newsdesk has researchers and writers with an excellent domain knowledge about the talent ecosystem, and the business environment. The team keeps a tab on the latest happenings in the ecosystem to bring most relevant news and insights for our readers. You can connect with our newsdesk at newsdesk@hrnxt.com.